This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Biogen Inc., Biologics Manufacturing Facility in Cambridge and Distribution Center in Somerville
Biogen Inc., a leading biotechnology company, is headquartered in the United States, with significant operations in Cambridge, Massachusetts, where its biologics manufacturing facility is located, and a distribution centre in Somerville. Founded in 1978, Biogen has established itself as a pioneer in the development of therapies for neurological diseases, including multiple sclerosis and spinal muscular atrophy. The company is renowned for its innovative biologics, which leverage advanced manufacturing techniques to deliver high-quality treatments. Biogen's commitment to research and development has positioned it as a key player in the biotechnology industry, with notable achievements such as the first approved treatment for spinal muscular atrophy. With a strong market presence, Biogen continues to drive advancements in patient care through its unique product offerings and dedication to scientific excellence.
DitchCarbon Score
How does Biogen Inc., Biologics Manufacturing Facility in Cambridge and Distribution Center in Somerville's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Biogen Inc., Biologics Manufacturing Facility in Cambridge and Distribution Center in Somerville's score of 50 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Biogen Inc., specifically its Biologics Manufacturing Facility in Cambridge and Distribution Center in Somerville, currently does not have publicly available emissions data for the most recent year. As a result, specific carbon emissions figures in kg CO2e are not provided. The organisation is part of a corporate family that cascades emissions data and climate commitments from Thermo Fisher Scientific Inc., with a cascade level of 3. This means that any climate initiatives or targets may be influenced by the broader commitments of Thermo Fisher Scientific Inc. However, no specific reduction targets or achievements have been detailed for Biogen's facilities. Biogen's climate commitments are aligned with industry standards, but specific initiatives or pledges, such as those under the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP), are not explicitly mentioned in the available data. The absence of detailed emissions data and reduction targets suggests that further transparency may be needed to fully assess Biogen's climate impact and commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 321,190,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 486,151,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Biogen Inc., Biologics Manufacturing Facility in Cambridge and Distribution Center in Somerville is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
